Patrys Ltd. engages in the commercialization of the group's proprietary technologies to develop natural human antibody-based therapeutic products for the treatment of cancer and the pursuit of non-dilutive funding sources. Its pipeline includes PAT-DX1 antibody fragment, PAT-DX3 full sized antibody, and PAT-DX1-NP conjugated to nanoparticles. The company was founded by Daniel Devine on December 8, 2006 and is headquartered in Nedlands, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Patrys Limited market cap is $42.53M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Patrys Limited 52 week high is $0.06 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Patrys Limited 52 week low is $0.05 as of November 18, 2026.
Patrys Limited stock price today is $0.06.
Patrys Limited stock price yesterday was $0.05.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Patrys Limited's P/E ratio is -7.69.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Patrys Limited P/B ratio is 6.2241.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Patrys Limited 50-day moving average is $0.06.